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Abstract
Hepatocellular carcinoma (HCC) is the sixth most common cancer and the third most com-
mon cause of cancer mortality worldwide. Infection with hepatitis B virus (HBV) and/or hepa-
titis C virus (HCV) is the most predominant cause of HCC. Concerns arise for the presence
of additional risk factors, as there is still a large proportion of patients without HBV or HCV
infection. Previous studies have reported that higher intake of fruits and vegetables and
reduced consumption of red/processed meat might play a protective role in HCC etiology,
though the nationwide proof is limited. Hence, we studied multiple risk factors including food
habit, lifestyle, and clinical implications of HCC patients in Bangladeshi. Demographic, clini-
cal, and biochemical data, as well as data on food habits, were collected in this study. Our
results indicated that a high intake of rice (AOR 4.28, 95% CI 1.48 to 14.07, p = 0.011), low
intake of fruits (AOR = 4.41 95% CI 1.48–15.46; p = 0.012), leafy vegetables (AOR = 2.80,
95% CI 1.32–6.08; p = 0.008), and fish (AOR = 4.64 95% CI 2.18–10.23; p<0.001)
increased the HCC risk. Moreover, a high intake of eggs (AOR = 2.07 95% CI 0.98–4.43; p
= 0.058) also showed an increased risk. Roti, non-leafy vegetables, red meat, and tea were
found to have no association with HCC risk. This study revealed that food habit patterns and
lifestyle may have a profound effect on HCC development among Bangladeshi patients in
addition to well established risk factors.
Introduction
Cancer that first develops in the liver is called primary liver cancer, and hepatocellular carci-
noma (HCC) is the most common one among them. 75%- 85% of primary liver cancers are
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attributed to HCC, while 10%-15% account for intrahepatic cholangiocarcinoma (ICC), and
the residual cases include other rare types [1]. The international agency for research on cancer
estimated approximately 0.84 million incidences and 0.78 million mortalities worldwide in
2018, which will rise to 1.36 million incidences and 1.28 million deaths by the year 2040. Liver
cancer is the sixth most commonly diagnosed cancer, and it was the third cause of mortality
worldwide in 2018 among all sexes. Rates of both incidence and mortality are 2 to 3 times
higher among men in most of regions worldwide [2]. Dynamic temporal trends, marked varia-
tions among geographic regions, racial and ethnic groups, and between men and women, and
the presence of several well-documented environmental potentially preventable risk factors
are several exciting epidemiologic features of HCC [3].
Several studies have shown that HCC occurs worldwide, mostly due to infection with hepa-
titis B virus (HBV). The other recognized risk factors for HCC include chronic hepatitis C
virus (HCV) infection, exposure to dietary aflatoxin, smoking, fatty liver disease, excessive
alcohol consumption, diabetes, etc. [4]. Recent evidence found a positive correlation between
obesity and increased risk of liver cancer through chronic inflammation [5]. Another risk fac-
tor is diabetes, which may also increase the risk of liver cancer [6]. The major risk factors vary
from region to region [1]. In China and Africa, which are the most high-risk HCC areas, the
major risk factors are chronic HBV infection and aflatoxin. On the other hand, in Japan and
Egypt, the primary risk factor is attributed to HCV infection [7,8]. People from low-risk HCC
areas are also prone to obesity and diabetes as a risk factor [9].
Bangladesh is one of the countries facing a considerable burden of HCC. HCC is the third
most common cancer in the country, and it is just behind lung cancer and stomach cancer
[10,11]. HBV infection is the leading cause of HCC in Bangladesh, which is estimated at 46.9%
to 61% [13,14]. However, there is not much information on the definite risk factors of HCC
and no appropriate and reliable data showing the etiological and epidemiological perspectives
yet.
Furthermore, there is no available data regarding the Bangladeshi population to understand
the cause of developing HCC in those patients who do not have any HBV or HCV infection.
Apart from the most common and defined etiological factors, the association of diet with the
development of HCC is unclear [10]. Previously, few studies were investigating the role of
food habits in the development of HCC worldwide. It is evident from those studies that food
habits may play an important role in HCC development. Different studies claimed an inverse
relation of milk [11], fiber and whole-grains [12], white meat [13], fruits and vegetables [14],
and fish [15] with HCC. In contrast, a high intake of red meat [13] has been associated with
increased risk of HCC; however, there is no sufficient evidence on the association between
HCC and egg consumption [16]. Therefore, intense investigations are required to develop
insights about clinical features, etiological factors, and epidemiology of HCC in Bangladesh. In
this study, we took an elaborate history of HCC patients, details of food habit patterns, smok-
ing and drinking habits, and also checked clinical profiles and etiological agents of HCC
patients. Our study sheds light on the association of HBV and HCV infection for the develop-
ment of HCC, as well as some other risk factors like food habit patterns, and smoking and
drinking habits for the development of HCC in Bangladeshi patients.
Materials and methods
Study population
In the present hospital-based case-control study, we observed 80 patients with HCC who
attended a tertiary care facility from November 2018 to July 2019. This facility is the largest
postgraduate public medical university in Bangladesh, located in the capital city, Dhaka, and
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acts as a reference center for patients having unmanageable diseases. After matching the demo-
graphic characteristics of HCC patients, such as age, sex, income, and sociodemographic sta-
tus, 101 control subjects were chosen. Among the patients visiting public hospitals in
Bangladesh, most are the poor and lower-middle-income groups. Hence, we assumed that
only this group of people represented the study population in this particular research study.
This study was approved by the ethical committee of that particular tertiary hospital and was
conducted according to the European Association for the Study of the Liver (EASL) clinical
practice guidelines for the management of hepatocellular carcinoma [17]. We clarified to the
participants the purpose and procedure of the study in detail, their benefits and risks, and sub-
sequently informed consents were obtained from both patients and controls.
Study design and sample size calculation
A matched case-control design was used for this study. The sample size was calculated based
on a conservative predictor such as intake of leafy vegetables and whether a low amount of
intake compared to moderate intake increases the odds of HCC. Assuming a prevalence of the
risk factor in the unexposed population to be 50%, to detect an odds ratio (OR) of at least 2.5
with 80% power with 95% confidence would require 162 subjects. The sample size was calcu-
lated using the R package epiR [18].
Patient selection
The inclusion criteria for patient choice include both male and female patients with HCC
regardless of etiology. The exclusion criteria included a) patients with additional cancer as well
as HCC and b) patients with co-morbid conditions such as severe congestive cardiac failure
(CCF), ischemic heart disease (IHD), chronic kidney disease (CKD), etc., and not fit for fine-
needle aspiration cytology (FNAC).
Diagnosis procedure
HCC has been diagnosed on the grounds of clinical and radiological characteristics (ultraso-
nography and computed tomography), followed by EASL clinical practice guidelines [17]. The
confirmation of HCC was done by cytopathology examination, collecting tissues through fine-
needle aspiration cytology (FNAC) technique [19,20]. Patients under 18 years of age were
excluded.
Clinical and biochemical evaluation
All patients were clinically assessed, and blood pressure level and Body Mass Index (BMI)
were recorded. Patients having a BMI of>25 kg/m2 were marked as obese, and patients with a
BMI of<25 kg/m2 were considered as non-obese. Patients’ blood samples were drawn under
fasting conditions, and the accompanying tests, for example, complete blood count (CBC),
albumin, total bilirubin, alanine aminotransferase (ALT), aspartate aminotransferase (AST),
international normalized ratio (INR), and alpha-fetoprotein (AFP) were performed for diag-
nosis purpose. Barcelona Clinic Liver Cancer (BCLC) staging and Child-Pugh scores were
determined from laboratory tests, and clinical features obtained from diagnostic reports.
Patients were categorized into four BCLC stages, for example, Early-stage, A; Intermediate
stage, B; Advanced stage, C; and Terminal stage, D. BCLC staging was determined by physi-
cian, and patients’ performance status, tumor size and number, Child-Pugh score and portal
vein involvement [17,21] were documented according to EASL guidelines.
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Data collection
We collected patients’ demographic, clinical, and biochemical information through an inter-
view with a structured questionnaire. Demographic information, such as age, sex, education,
earnings, food habits, HCC etiologies, and first presenting symptoms were collected. Diverse
clinical and biochemical information such as serum levels of total bilirubin, albumin, INR,
AFP, aspartate aminotransferase, alanine aminotransferase, presence of ascites, hepatic
encephalopathy, hepatomegaly, splenomegaly, was collected from patient’s diagnostics reports.
A liver radiologist deliberately looked into patients’ computed tomography (CT), and ultraso-
nography report and the size, area, number of tumor lesions, portal vein thrombosis were
noted. Child-Pugh classification and BCLC staging of the patients were recorded.
Assessment of dietary habit
The data on food consumption per capita were obtained by an interview-based, structured
questionnaire. The survey incorporated the food habit pattern from both cases (n = 80) and
controls (n = 101). Through a case-control statistical analysis, we explored the link between
food habit patterns and HCC development. In the case of fruits and vegetables, seasonal con-
sumption and the corresponding duration are subject to variation. The dietary items included
82 foods or food groups and were divided into 9 sections: i) rice (primary course); ii) bread,
and roti (secondary course); iii) leafy vegetables (water spinach, pumpkin leaves, taro stem,
Indian spinach, spinach, red amaranth, cauliflower, cabbage); iv) non-leafy vegetables (okra,
tomato, balsam apple, eggplant, carrot, pumpkin, potatoes, sweet potatoes); v) meat and meat-
based food items such as burger, sandwich; vi) fish (both river and ocean); vii) milk, tea, coffee,
sugar, tea with condensed milk; viii) fruit (litchis, mangoes, jackfruits, blackberries, dates, gua-
vas, pineapple, papayas, bananas, watermelon, coconuts, apples, grapes, oranges, tropical
fruits, etc.); ix) sweets, rice-based desserts, and soft drinks. The selection of food items was
based on foods regularly consumed by the Bangladeshi people. The standard serving size was
obtained from the dietary guidelines from BIRDEM (Bangladesh Institute of Research and
Rehabilitation in Diabetes, Endocrine, and Metabolic Disorders) [22]. We focused on the
above-mentioned food items to explore the relationship between these food groups and the
advancement of HCC in the Bangladeshi population. The consumption rate among our case-
control population of targeted food groups was transformed into g/day or ml/day. In the case
of tea it was considered as cup/day. Consumption of specific food items of more than the sug-
gested value is defined as “high intake.”
In contrast, the consumption of specific food items of lower than the suggested value is
defined as “low intake.” A recent report suggested an inverse association of tea intake with pri-
mary liver cancer; however, the preparation of tea in Bangladesh or South Asia is different
compared to Western countries. In Bangladesh, condensed milk with sugar is commonly used
to prepare the tea. Moreover, the tea leaves are usually continuously boiled for a long time.
Hence, we investigated the primary or combined effect of tea drinking on the risk of HCC
with or without the presence of other risk factors.
Statistical analysis
Data management and statistical analysis were performed using R statistical software [18].
Continuous variables were expressed as mean ± standard deviation, and categorical variables
were presented as numbers and percentages or frequencies. The Chi-square (χ2) test with con-
tinuity correction was employed to find significant differences between groups. Crude and
adjusted odds ratios were calculated using the multiple logistic regression model. For the
regression strategy, we first performed bivariate analysis of the potential factors with the
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outcome variable of interest. If the bivariate results were significant at 20% level, we considered
them in the regression model. In addition, certain variables were included in the model for
their importance from demographic and clinical perspectives regardless of the results of the
bivariate analysis. These included age, sex, diabetes status, and weight status (overweight or
normal). The analysis was performed to assess the effect of risk factors on the likelihood of
developing HCC. A p-value<0.05 was considered as statistically significant.
Results
Demographic characteristics of the study sample
In the present study, patients of both sexes, with different age groups, social, marital, educa-
tional, and professional backgrounds have been selected (Table 1). Our sample consisted of 80
study patients and 101 healthy controls. Of the study subjects, 64 were male, and 16 were
female with a calculated sex ratio of 4:1. The mean age of the study population was 48.7±14.8
years and 47.1±14.2 years for the controls. The mean Body Mass Index (BMI) was calculated
as 23.8±2.6 for the study group and 23.7±2.7 for the controls. For both study and control
groups, there were more patients with no education, followed by patients with the primary
education level completed. These two categories comprised two- thirds of the total study popu-
lation. A large subset of patients (20 cases and 23 controls) was employed by the government
or in non-government services. Regarding the employment, the highest category (21 patients)
was found for people involved in different kinds of businesses, and 15 patients were farmers.
Among 16 women in the study population, 14 were housewives. While we shed light on eco-
nomic solvency based on income level, roughly 58% of the patients had an income between
20,000–50,000 BDT per month. More than 90% of the patients were married, and about 73%
lived in rural areas.
Etiological factors
Fig 1 outlines the etiological variables of our study sample. As it is already recognized that the
most common etiology for HCC is cirrhosis of the liver, 78% (62) of our HCC patients also
reported cirrhosis leading to HCC. Next, we found smoking (50% reporting) as a risk factor
followed by HBV infection, which accounted for 39 (49%) of our patients. We found only 6
(8%) patients having HCV infection. There were no patients diagnosed jointly infected with
both hepatitis B and hepatitis C viruses. Surprisingly, 35 (44%) patients were found to be nega-
tive for both hepatitis B and hepatitis C infections. 23 (29%) of the patients were diabetic while
17 (21%) had both diabetes and positive HBV/HCV infection. While smoking together with
hepatitis B was the sole etiology for 22 (28%) patients, only 3 (4%) patients had the etiological
history of smoking along with hepatitis C. Consumption of alcohol alone as etiology accounted
for only 3 patients (4%). Alcohol consumption, however, is not very common in Bangladesh
due to religious restriction and strict state law. Only 2 (2%) patients with alcohol intake along
with hepatitis B were registered. However, there were no patients with hepatitis C reporting
alcohol consumption. Given a large proportion of cirrhosis positive HCC patients with smok-
ing behavior, we compared the smoking behavior and development of cirrhosis (Table 2). The
result suggests the odds of developing cirrhosis for those who smoke is more than four times
compared to those who do not smoke.
First clinical symptoms of HCC patients
The first clinical symptoms of HCC patients are shown in Fig 2. Practically the majority of the
patients in our study were symptomatic. In most cases, one patient had multiple symptoms.
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Table 1. Sociodemographic and food intake characteristics of HCC patients and the controls.
Label Levels Control HCC p
Total N (%) 101 (55.8) 80 (44.2)
Age in years Mean (SD) 47.1 (14.2) 48.7 (14.8) 0.461
Sex F 20 (19.8) 16 (20.0) 0.974
M 81 (80.2) 64 (80.0)
BMI Mean (SD) 23.7 (2.7) 23.8 (2.6) 0.988
Education (level completed) No Education 41 (40.6) 36 (45.0) 0.748
Primary 29 (28.7) 25 (31.2)
Secondary 9 (8.9) 8 (10.0)
Higher Secondary 12 (11.9) 6 (7.5)
Graduate 10 (9.9) 5 (6.2)
Occupation Business 34 (33.7) 21 (26.2) 0.883
Farmer 17 (16.8) 15 (18.8)
Housewife 16 (15.8) 14 (17.5)
Labor and Other 11 (10.9) 10 (12.5)
Service 23 (22.8) 20 (25.0)
Income (BD Taka) 1: 1–20,000 7 (6.9) 4 (5.0) 0.784
2: 20,001–50,000 60 (59.4) 46 (57.5)
3: > 50,000 34 (33.7) 30 (37.5)
Place of residence Rural 75 (74.3) 58 (72.5) 0.790
Urban 26 (25.7) 22 (27.5)
Marital status Married 91 (90.1) 77 (96.2) 0.111
Unmarried 10 (9.9) 3 (3.8)
Smoker No 71 (70.3) 40 (50.0) 0.005
Yes 30 (29.7) 40 (50.0)
Diabetes No 75 (74.3) 57 (71.2) 0.651
Yes 26 (25.7) 23 (28.7)
Rice intake High 72 (71.3) 74 (92.5) <0.001
Moderate 29 (28.7) 6 (7.5)
Roti/Bread Low 66 (65.3) 61 (76.2) 0.111
Moderate 35 (34.7) 19 (23.8)
Egg intake High 38 (37.6) 50 (62.5) 0.001
Moderate 63 (62.4) 30 (37.5)
Tea with condensed milk No 49 (48.5) 33 (41.2) 0.330
Yes 52 (51.5) 47 (58.8)
Tea with tea-bag No 76 (75.2) 62 (77.5) 0.724
Yes 25 (24.8) 18 (22.5)
Leafy vegetable intake Low 43 (42.6) 55 (68.8) <0.001
Moderate 58 (57.4) 25 (31.2)
Non-leafy vegetable intake Low 48 (47.5) 36 (45.0) 0.735
Moderate 53 (52.5) 44 (55.0)
Fruit intake Low 73 (72.3) 75 (93.8) <0.001
Moderate 28 (27.7) 5 (6.2)
Fish intake Low 38 (37.6) 62 (77.5) <0.001
Moderate 63 (62.4) 18 (22.5)
Milk intake Low 55 (54.5) 66 (82.5) <0.001
Moderate 46 (45.5) 14 (17.5)
Red meat intake High 10 (9.9) 6 (7.5) 0.572
(Continued)
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The most significant number of patients were recorded with upper abdominal pain, nearly 70
(88%). Around 67 (84%) patients lost weight during the disease period. A large proportion of
HCC patients had anorexia, about 62 (78%). There were some other complications such as
pain in the right shoulder, fever, headache, and vomiting reported by 42 (52%), 51 (64%), 36
(45%), and 33 (41%) patients, respectively.
Clinical characteristics of HCC patients
The medical records of 73 patients were reviewed and illustrated in Table 3. Many patients
were unable to bear the costs of all biochemical and radiological diagnosis due to poor finan-
cial conditions. Some patients were not willing to provide their medical records. As a conse-
quence, every patients’ diagnosis report was not accessible. Therefore, we mention the actual
numbers of each parameter, which is the total number of HCC. In our cohort of study, the
majority of patients 43 (66.2%) had a single nodule. Many of them 26 (45.6%) had a nodule
size of 5–10 cm. Different clinical features were depicted by patients, with 50 patients with
hepatomegaly (72.5%), followed by 31 patients (44.9%) with splenomegaly. In addition, mild
ascites was observed in 27 patients (38.6%), and 39 patients (55.7%) showed no ascites. Portal
vein thrombosis was noted distinctly for 17 patients (24.6%) and 14 patients (19.4%) showed
mild encephalopathy. The Child-Pugh score is a system determined by scoring five clinical
Table 1. (Continued)
Label Levels Control HCC p
Moderate 91 (90.1) 74 (92.5)
White meat intake Low 35 (34.7) 40 (50.0) 0.037
Moderate 66 (65.3) 40 (50.0)
https://doi.org/10.1371/journal.pone.0232121.t001
Fig 1. Underlying etiologies of Bangladeshi HCC patients. HBV = hepatitis B virus, HCV = hepatitis C virus.
https://doi.org/10.1371/journal.pone.0232121.g001
PLOS ONE Hepatocellular carcinoma in Bangladesh
PLOS ONE | https://doi.org/10.1371/journal.pone.0232121 April 27, 2020 7 / 18
measures such as total bilirubin, serum albumin, prothrombin time, ascites, and hepatic
encephalopathy for evaluating the prognosis of liver disease. It serves as a liver function marker
and helps to determine appropriate treatment. Child-Pugh class A, B, and C are classified
based on severity, with C being the most severe. As indicated by our study, most patients had
Child-Pugh class A, 35 (47.9%), and B, 31 (42.5%).
Barcelona Clinic Liver Cancer (BCLC) staging and treatment
The magnitude of the tumor has been staged according to the BCLC classification (Table 4).
Early HCC (stage A) was categorized in 4 patients (5.5%). Furthermore, 40 patients (54.8%)
and 27 patients (37%) were categorized respectively as stages B and C. A total of 2 patients
(2.7%) were categorized as stage D. Table 3 shows the treatment modalities used in our
patients at various BCLC stages. Patients underwent ablation in stage A, and chemoemboliza-
tion in stage B. On the other hand, patients in stage C underwent systemic therapy and clini-
cians suggested best supportive care (BSC) in the event of stage D.
Alpha-fetoprotein (AFP) levels as a marker for HCC
AFP is a tumor marker protein that can increase significantly in case of liver damage and cer-
tain other cancers. In our study we have documented the AFP levels of 73 patients, which have
been shown in Table 5. As indicated by our study, 4 (100%) patients with BCLC stage A had
AFP levels greater than 1000 ng/ml. In the case of stages B and C, AFP levels were found to be
higher than 1000 ng/ml for 20 (50%) and 18 (66.6%) patients, respectively, whereas for 19
(47.5%) and 7 (26.0%) patients, levels lower than 200 ng/ml were observed. Two out of 73
patients had BCLC stage D with AFP levels greater than 1000 ng/ml.
Association of food habits with the risk of HCC
In the present study, we intended to focus on the association between food habits and the risk
of HCC in Bangladesh. An approved food frequency questionnaire (FFQ) was used to evaluate
the habitual diet of the study subjects and healthy controls. To select the variables for the
regression model, we used predictors that were found to be significant at the alpha = 10% level
in the bivariate analysis. However, to further control demographic confounders, we kept age
and sex in the model, although they are not significantly different between the two groups.
Table 6 represents the ordered distribution of the total number of individuals consuming
low, moderate, or high amounts of particular food items, and the crude and adjusted odds
ratios with 95% confidence intervals for HCC. Adjusted for other factors, the odds of develop-
ing HCC was 4.34 times for those with high rice intake compared to moderate intake (95% CI:
1.49–14.42, p = 0.010). Similarly, low intake of leafy vegetables (AOR 2.8, 95% CI 1.3 to 6.03,
p = 0.009), low fruit intake compared to moderate (AOR 4.40, 95% CI: 1.47–15.51, p = 0.012),
and low fish intake compared to moderate (AOR 4.64, 95% CI: 2.18–10.26, p<0.001) increase
the odds of HCC significantly. On the other hand, no significant association was found in the
case of white meat, milk intake, having diabetes, and weight status (obese or normal). Age and
Table 2. Smoking behavior between cirrhosis positive and cirrhosis negative HCC patients.
Cirrhosis
No Yes Total
No 14 (77.8) 26 (41.9) 40 (50.0)
Yes 4 (22.2) 36 (58.1) 40 (50.0)
Total 18 62 80
https://doi.org/10.1371/journal.pone.0232121.t002
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Fig 2. Percentage distribution of first clinical symptoms of HCC patients. Multiple responses possible, therefore the percentages will not add up to 100%.
https://doi.org/10.1371/journal.pone.0232121.g002
Table 3. Clinical characteristics of HCC patients.
Parameter Patients, N (%)
Tumor size (cm) Mean (SD) 8.4 (3.7)
Tumor size (binned) <5 cm 13 (22.8)
5–10 cm 26 (45.6)
>10 cm 18 (31.6)
Number of tumors Single 43 (66.2)
Multiple 22 (33.8)
Portal vein thrombosis No 52 (75.4)
Yes 17 (24.6)
Hepatomegaly No 19 (27.5)
Yes 50 (72.5)
Splenomegaly No 38 (55.1)
Yes 31 (44.9)
Ascites None 39 (55.7)
Mild 27 (38.6)
Severe 4 (5.7)
Encephalopathy None 58 (80.6)
Mild 14 (19.4)
Severe 0 (0.0)
Child-Pugh score A 35 (47.9)
B 31 (42.5)
C 7 (9.6)
https://doi.org/10.1371/journal.pone.0232121.t003
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sex were matched for the study, and as a result, they demonstrated no significance on the risk
of HCC.
Interestingly, this study found 35 (44%) patients negative for both hepatitis B and hepatitis
C infections. Hence, it is important to investigate whether any particular food group is primar-
ily responsible for potential HCC risk. However, we did not observe any statistically significant
difference in food habits, when comparing the patients who were hepatitis B or C positive with
the rest of the patients (categorized as ‘Other’) (S1 Table).
Discussion
In the present study, we characterized HCC patients in Bangladesh according to HBV and
HCV infection, as well as some other risk factors like food habit patterns, smoking, and drink-
ing habits for the first time regarding the Bangladeshi perspective. We represented unique pro-
files in terms of demographic factors, etiologies, disease-specific clinical representation,
staging and treatment options, biomarker profiles, and an association of food habit patterns
with the development of HCC for those patients. This represents the first-ever elaborated
study accompanying factors other than HBV and HCV infection as a predominant cause of
HCC in Bangladesh.
Among the 80 patients we studied, the male predominance was found, which is not surpris-
ing as it is evident that males are more susceptible to HCC than females [23]. In almost all pop-
ulations, male to female ratios usually average between 2:1 and 4:1 [3]. In our study, the male
to female ratio was found to be 4:1. This is due to the sex-specific differences in exposure to
the risk factors, because they are more likely to be infected with HBV and HCV, as well as alco-
hol consumption, cigarette smoking, and food habits. The liver is a hormone-sensitive organ,
that’s why sex hormones, such as androgen and estrogen, maybe an acting factor. It is assumed
that androgen promotes HCC development, whereas estrogen plays a protective role [24–26].
The typical age group affected by HCC was 50–59 and 60–69, as we have found most patients
corresponded to this age group. In a study performed in Bangladesh, a group found 41 to 50
years as the most common age group to develop HCC [27]. In the United States, from the year
1992 to 2013 the age-specific incidence rate was highest in the age group of 50–69. However, a
significant number of patients were also found above the age of 70 [28]. The mean age of our
study population was 48.71±14.8 years. The study conducted by Gani et al. (2013) comprised
Table 4. Barcelona Clinic Liver Cancer staging (BCLC) and treatment.
Label Levels Ablation BSC Chemoembolization Systemic therapy Total
BCLC stage A 4 (100.0) 0 (0.0) 0 (0.0) 0 (0.0) 4 (5.5)
B 0 (0.0) 0 (0.0) 40 (100.0) 0 (0.0) 40 (54.8)
C 0 (0.0) 0 (0.0) 0 (0.0) 27 (100.0) 27 (37.0)
D 0 (0.0) 2 (100.0) 0 (0.0) 0 (0.0) 2 (2.7)
https://doi.org/10.1371/journal.pone.0232121.t004
Table 5. The range of AFP levels according to BCLC staging.
Label Levels <200 200–1000 >1000 Total
BCLC stage A 0 (0.0) 0 (0.0) 4 (100) 4 (5.5)
B 19 (47.5) 1 (2.5) 20 (50) 40 (54.8)
C 7 (26.0) 2 (7.4) 18 (66.6) 27 (37.0)
D 0 (0.0) 0 (0.0) 2 (100) 2 (2.7)
Normal range of AFP < 15ng/ml
https://doi.org/10.1371/journal.pone.0232121.t005
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57 HCC patients where the mean age was 45.81 ± 15.31 years. The educational background
represents the lack of awareness and knowledge, as a large proportion of patients had no edu-
cation. According to the income level, most of the patients were of lower or lower-middle-
income group and most of the patients were of rural origin. These represent the economic
constraints to accessing necessary tests and treatments as well as the lack of suitable medical
care in rural areas. HCC has always been a very much neglected disease in Bangladesh as most
of the patients lack the economic capability and they also do not have proper knowledge about
HCC. Other risk factors are a lack of medical facilities and delay of diagnosis [29].
Chronic HBV and HCV infection is considered as one of the leading causes of the appear-
ance of HCC in Bangladesh [29,30]. Despite the introduction of vaccination during 2003–2005
into the Expanded Program on Immunization (EPI) in Bangladesh, HBV infection remains
abundant in the middle and older age adult population. Our data showed that chronic HBV
was the significant risk factor contributing to the development of HCC, which is similar to the
previous report [29] and also similar with our neighboring country India [31]. Although HCV
is considered one of the leading causes of the appearance of liver cancer in many countries
[32,33], in our study, HCV infection was found in only 8% of patients. Alcohol consumption is
another risk factor of HCC in Western countries [34,35]. In our study, only 4% of patients,
including one patient with HBV infection, were found consuming alcohol as alcohol con-
sumption is strictly restricted in Bangladesh by state law. Alcohol consumption is also very
much restricted due to socioeconomic conditions and religious restrictions. According to our
study, we found no significant value for alcohol as an individual risk factor. Donato et al. [36]
Table 6. Risk factors associated with HCC: Results of multiple linear logistic regression analysis.
Dependent: Subject Control HCC OR (univariable) OR (multivariable)
Age Mean (SD) 47.1 (14.2) 48.7 (14.8) 1.01 (0.99–1.03, p = 0.455) 1.01 (0.98–1.04, p = 0.445)
Sex F 20 (55.6) 16 (44.4) - -
M 81 (55.9) 64 (44.1) 0.99 (0.47–2.08, p = 0.974) 0.87 (0.33–2.35, p = 0.783)
Smoker No 71 (64.0) 40 (36.0) - -
Yes 30 (42.9) 40 (57.1) 2.37 (1.29–4.40, p = 0.006) 1.73 (0.78–3.86, p = 0.180)
Rice intake Moderate 29 (82.9) 6 (17.1) - -
High 72 (49.3) 74 (50.7) 4.97 (2.07–13.90, p = 0.001) 4.34 (1.49–14.42, p = 0.010)
Egg intake Moderate 63 (67.7) 30 (32.3) - -
High 38 (43.2) 50 (56.8) 2.76 (1.52–5.11, p = 0.001) 2.08 (0.98–4.48, p = 0.059)
Leafy vegetable intake Moderate 58 (69.9) 25 (30.1) - -
Low 43 (43.9) 55 (56.1) 2.97 (1.62–5.56, p = 0.001) 2.76 (1.30–6.03, p = 0.009)
Fruit intake Moderate 28 (84.8) 5 (15.2) - -
Low 73 (49.3) 75 (50.7) 5.75 (2.28–17.66, p = 0.001) 4.40 (1.47–15.51, p = 0.012)
Fish intake Moderate 63 (77.8) 18 (22.2) - -
Low 38 (38.0) 62 (62.0) 5.71 (3.00–11.30, p<0.001) 4.64 (2.18–10.26, p<0.001)
Milk intake Moderate 46 (76.7) 14 (23.3) - -
Low 55 (45.5) 66 (54.5) 3.94 (2.00–8.14, p<0.001) 2.05 (0.87–4.95, p = 0.104)
White meat intake Moderate 66 (62.3) 40 (37.7) - -
Low 35 (46.7) 40 (53.3) 1.89 (1.04–3.45, p = 0.038) 1.64 (0.75–3.59, p = 0.214)
Diabetes No 75 (56.8) 57 (43.2) - -
Yes 26 (53.1) 23 (46.9) 1.16 (0.60–2.25, p = 0.651) 1.01 (0.42–2.37, p = 0.991)
Weight status Normal 73 (53.7) 63 (46.3) - -
Overweight 28 (62.2) 17 (37.8) 0.70 (0.35–1.39, p = 0.318) 0.81 (0.33–1.98, p = 0.649)
Number in data set = 181, Number in model = 181, Missing = 0, AIC = 196.9, C-statistic = 0.857, H&L = Chi-sq(8) 6.38 (p = 0.605)
https://doi.org/10.1371/journal.pone.0232121.t006
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examined the association between alcohol intake and HCC and found that for each level of
alcohol intake, the highest risks were observed among subjects with HCV infection, followed
by those with HBV infection, and finally by those without hepatitis virus infection. So, alcohol
consumption is not an independent important risk factor in Bangladesh. In our study, we
found 50% of patients were chain smokers and most of them had no HBV and HCV infection.
The relationship between cigarette smoking and HCC has been examined in many studies. In
almost all studies, both positive-association [37–39] and lack-of-association [38] have been
reported.
According to our study, smoking persisted as an independent risk factor in our country.
The effect of smoking was also found to be an independent risk factor for HCC in previous
studies [40,41]. Furthermore, smoking has been reported to increase the risk of development
of HCC in people with HCV, HBV [42]. A synergistic combined effect of HBV/HCV and
smoking might act mostly through increased risk of HCC (Fig 1). So, there could be a synergis-
tic interaction between tobacco smoking and HBV/HCV for the development of HCC in Ban-
gladeshi patients. In our study we found 29% of patients were diabetic. The association
between diabetes mellitus type II was found as an individual risk factor in other studies [43].
Though diabetes did not emerge as a strong individual risk factor in our study, we found a syn-
ergistic combined effect of HBV/HCV and diabetes for the development of HCC (Fig 1). Nev-
ertheless, we did not observe any impact of obesity on the odds of HCC in our multivariate
logistic regression model (Table 6).
In our study, we collected the first clinical symptoms that have been observed while the
patients were admitted to the hospitals. It was evident that every patient came with multiple
clinical symptoms which were representative symptoms of HCC. The habit of Bangladeshi
patients avoiding clinical checkups and regular screening of disease has become a significant
influence on the development of devastating diseases, including HCC. The major factors
behind this are poverty and lack of education and awareness, which we have already men-
tioned. After being admitted to hospital, different imaging reports such as CT scan, ultra-
sonographies, biochemical tests, and tumor markers were used for the detection of presence or
severity of HCC. In Bangladesh, as mentioned before the diagnosis of the disease is usually
delayed. As a result, the patients developed in BCLC stage B (intermediate stage) and C
(advanced stage). Most of the patients of our study were in stage B and stage C. The BCLC
staging was determined according to the patients’ albumin, bilirubin, ascites, encephalopathy,
imaging reports, tumor size, portal vein invasion, tumor site, Child-Pugh score, and pro-
thrombin activity.
The BCLC staging helps in the decision of treatment options available for the patients by
the clinicians. It narrows down the treatment options to provide particular treatments to the
patients. Due to resource constraints and lack of treatment facilities, in addition to the limita-
tion mentioned above, the treatment options were optimized to the most affordable options.
Commonly, the patients of stage A were given ablation therapy, stage B patients were given
chemoembolization, and stage C patients were given chemotherapy. Liver transplantation is
not a popular treatment option in Bangladesh due to its high cost and other difficulties. Clini-
cians also try to avoid providing these treatment options to the patients. If any patients needed
surgery, they were transferred to the surgery department. But in most of the cases, the hepatol-
ogy department provides the ablation, chemoembolization, and chemotherapy without refer-
ring the patients to the surgery. In addition to the BCLC staging, AFP level which is a tumor
marker helps in the diagnosis of HCC as well as provide insights into the treatment pattern.
Although the role of diet in the etiology of hepatocellular carcinoma is unclear, evidence
suggests that dietary intake of particular food groups may have a favorable or adverse associa-
tion with the risk of HCC [44]. For example, consumption of vegetables and fruits may have
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an inverse connection, while consumption of red meat can increase the risk of HCC. Not
many studies have been evaluated to explore the link between food intake and liver cancer,
either in our country or globally. In our study, analysis of dietary habits of HCC patients and
controls indicated that diet has a relevant role in HCC risk. Rice is the staple food of the Ban-
gladeshi population. Our study found a significant association of high rice intake with
increased HCC risk. Previously, there was no evidence of association of rice intake with HCC
risk; however, one study found null association between total carbohydrate intake and HCC
risk [45]. As Bangladeshi people are more likely to eat rice frequently, it is relevant that rice
may play a role as a dietary risk factor for HCC. Red meat has long been recognized as a dietary
risk factor for HCC and significantly it has been proven that it has a positive relation with
increased HCC risk. Huang et al. (2003) suggested that red meat intake may increase the risk
of HCC. The polymorphism of the N-acetyltransferase 2 (NAT2) gene plays a role increasing
the susceptibility of the effect of red meat in HCC development [46]. Cross et al. (2007) found
that, red meat intake was associated with an elevated risk for liver cancer [47]. Red meat is the
main source of heme iron and may increase HCC risk via the possible effect of iron such as
hepatocyte injury and death and DNA damage in tissues by catalyzing lipid peroxidation [48].
In the current scenario, the red meat consumption in Bangladesh is limited due to its very
high price and most poor people’s intake of red meat is in moderate or low amounts. The
amount of consumption and also the frequency of consumption may play an important role
for being a significant dietary factor for HCC development. In the perspective of our study, red
meat has no association with increased risk of HCC. In our study, higher egg consumption
was found to have significance for increased risk of HCC. However, two Italian studies sug-
gested an inverse association between higher egg consumption and increased HCC risk
[10,49]. The study by Bamia et al. (2014) found an inverse association of tea intake with HCC
risk, which was attributed to the presence of polyphenols as an antioxidant, especially in green
tea [50]. Our study was unable to retrieve any significant association between tea intake and
HCC risk. Roti is also consumed in Bangladesh as a primary source of carbohydrates. The
present study found no significant association of roti intake and risk of HCC. Leafy vegetables
are group of crop plants that are grown for their edible leaves. Examples of leafy vegetables are
various types of spinach, cabbage, parsley, and lettuce. However, the distinction between leafy
and non-leafy vegetables is not always clear. Non leafy vegetables are potato, cucumber,
tomato, eggplant, cauliflower, etc. While investigating the association of vegetables, we classi-
fied them as the above mentioned two groups. Surprisingly, we found significant association
of lower intake of leafy vegetables with higher HCC risk. In other words, an increased intake of
leafy vegetables might decrease the risk of HCC. We found no significant association between
non-leafy vegetables and HCC risk. A prospective cohort study in Japan showed inverse asso-
ciations between the consumption of vegetables, green–yellow and green leafy vegetables and
HCC risk [51]. An association of overall vegetable consumption with reduced HCC risk was
also found in studies conducted in China [52], Serbia [53], Japan [54], and Italy [49]. It is also
noteworthy that another study conducted in Greece found no association of vegetable intake
with risk of HCC [55]. Our study found that higher consumption of fruits is significantly asso-
ciated with decreased HCC risk. The role of fruit consumption in HCC risk is not properly
established as there is substantial evidence of both association and no association. Talamini
et al. (2006) and Vecchia et al. (1988) suggested a positive association of higher fruit intake
with lower HCC risk [10,49]. In contrast, Yang et al. (2014) and Bamia et al. (2015) found no
significant association [56,57]. The major fact is that vegetables and fruits are major sources of
vitamins, minerals, antioxidants, and many bioactive compounds which are major effectors
against cancer [44]. That’s why vegetable and fruit intakes are more likely to contribute to the
prevention of cancer. Vegetables and fruits are also a major source of dietary fiber. The
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association of dietary fiber with decreased risk of HCC was found in a study conducted by
Fedirko et al. (2012) [45]. In the case of fish and milk, we found that, increased consumption
of these food items may reduce the risk of HCC. In other words, lower consumption of fish
and milk have positive association with HCC risk. Higher consumption of white meat is evi-
dent in several studies to have a positive impact on reduced HCC risk [10,58,59] and no other
studies have reported results dissimilar to these studies. Fish intake is also proven to have an
inverse association with increased HCC risk in previous studies [60,61]. The supporting factor
is that a diet rich in linoleic acid in foods such as white meats and fish, was inversely related to
HCC risk [62]. White meat and fish have less saturated fat and are rich in polyunsaturated
fatty acids (PUFA) [48]. HCC prevention is attributed to the function of n-3 PUFA, which pos-
sesses anti-inflammatory activity by inhibiting interleukin-1 and tumor necrosis factor [63].
Milk consumption is not widely studied. However, there is also supporting evidence of higher
milk consumption with reduced HCC risk in a previous study [10].
From our study, it is evident that diet and food habits may play an essential role in the
increased risk of HCC in the Bangladeshi population. Given cirrhosis is the major cause of
HCC, the role of nutrition in the development of cirrhosis vs HCC warrants further research.
In the perspective of our study, comparing the food habit pattern between cirrhosis positive
and negative HCC patients did not give any significance due to the small number of valid
responses (n = 80), and low number of responses per category per risk factor. We believe,
more intense research is required to find out the exact mechanism for the association of food
habits with the risk of HCC as an additional risk factor other than already established risk
factors.
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